Nathan Lawrentschuk

Austin Health ORCID: 0000-0001-8553-5618

1

h-index

1

Publications

1,768

Citations

Publications

1 shown

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

Michael S. Hofman , Nathan Lawrentschuk , Roslyn J. Francis +23 more

2020 The Lancet 1768 citations

Frequent Co-Authors

Michael S. Hofman

Peter MacCallum Cancer Centre

Roslyn J. Francis

Sir Charles Gairdner Hospital

Colin Tang

Sir Charles Gairdner Hospital

Ian Vela

Princess Alexandra Hospital

Paul Thomas

Royal Brisbane and Women's Hospital

Natalie Rutherford

Hunter New England Local Health District

Researcher Info

h-index: 1
Publications: 1
Citations: 1,768
Institution: Austin Health

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-8553-5618

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.